Citation Tools
PDFRegular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
443 Pembrolizumab for BCG refractory non-muscle invasive bladder cancer yields poor recurrence-free survival and high toxicity in patients
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 443 Pembrolizumab for BCG refractory non-muscle invasive bladder cancer yields poor recurrence-free survival and high toxicity in patients